Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Transformation by v-Myb

Abstract

The v-myb oncogene of the avian myeloblastosis virus (AMV) is unique among known oncogenes in that it causes only acute leukemia in animals and transforms only hematopoietic cells in culture. AMV was discovered in the 1930s as a virus that caused a disease in chickens that is similar to acute myelogenous leukemia in humans (Hall et al., 1941). This avian retrovirus played an important role in the history of cancer research for two reasons. First, AMV was used to demonstrate that all oncogenic viruses did not contain a single cancer-causing principle. In particular, although both Rous sarcoma virus (RSV) and AMV could replicate in cultures of either embryonic fibroblasts or hematopoietic cells, RSV could transform only fibroblasts whereas AMV could transform only hematopoietic cells (Baluda, 1963; Durban and Boettiger, 1981a). Second, chickens infected with AMV develop remarkably high white counts and therefore their peripheral blood contains remarkably large quantities of viral particles (Beard, 1963). For this reason AMV was often used as a prototypic retrovirus in order to study viral assembly and later to produce large amounts of reverse transcriptase for both research and commercial purposes.

Following the discovery of the v-src oncogene of RSV and the demonstration that it arose from the normal c-src proto-oncogene, a number of acute leukemia viruses were analysed by similar techniques and found to also contain viral oncogenes of cellular origin (Roussel et al., 1979). In the case of AMV, it was shown that almost the entire retroviral env gene had been replaced by a sequence of cellular origin (initially called mab or amv, but later renamed v-myb) (Duesberg et al., 1980; Souza et al., 1980). Remarkably, sequences contained in this myb oncogene were shared between AMV and the avian E26 leukemia virus, but were not contained in any other acutely transforming retroviruses. In addition, the E26 virus contained a second sequence of cellular origin (ets) that was unique. The E26 leukemia virus was first described in the 1960s and causes an acute erythroblastosis in chickens, more reminiscent of the disease caused by avian erythroblastosis virus (AEV) than by AMV (Ivanov et al., 1962).

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Badiani PA, Kioussis D, Swirsky DM, Lampert IA and Weston K. . 1996 Oncogene 13: 2205–2212.

  • Baluda MA. . 1963 Cold Spring Harbor Symposium on Quantitative Biology 27: 415–425.

  • Baluda MA and Goetz IE. . 1961 Virology 15: 185–199.

  • Baluda MA and Reddy EP. . 1994 Oncogene 9: 2761–1774.

  • Bartunek P, Karafiat V, Dvorakova M, Zahorova V, Mandikova S, Zenke M and Dvorak M. . 1997 Oncogene 15: 2939–2949.

  • Beard JW. . 1963 Advances in Cancer Research 7: 1–127.

  • Beug H, Leutz A, Kahn P and Graf T. . 1984 Cell 39: 579–588.

  • Beug H, von Kirchbach A, Doderlein G, Conscience JF and Graf T. . 1979 Cell 18: 375–390.

  • Biedenkapp H, Borgmeyer U, Sippel AE and Klempnauer KH. . 1988 Nature 335: 835–837.

  • Bizub D, Katz RA and Skalka AM. . 1984 J. Virol. 49: 557–566.

  • Boettiger D and Durban EM. . 1984 J. Virol. 49: 841–847.

  • Bortner DM and Ostrowski MC. . 1991 Nucleic. Acids Res. 19: 1533–1539.

  • Boyle WJ, Lampert MA, Lipsick JS and Baluda MA. . 1984 Proc. Natl. Acad. Sci. USA 81: 4265–4269.

  • Boyle WJ, Lipsick JS, Reddy EP and Baluda MA. . 1983 Proc. Natl. Acad. Sci. USA 80: 2834–2838.

  • Breitman TR, Selonick TE and Collins SJ. . 1980 Proc. Natl. Acad. Sci. USA 77: 2936–2940.

  • Brightman BK, Pattengale PK and Fan H. . 1986 J. Virol. 60: 68–81.

  • Burk O and Klempnauer KH. . 1991 EMBO J. 10: 3713–3719.

  • Burk O, Worpenberg S, Haenig B and Klempnauer KH. . 1997 EMBO J. 16: 1371–1380.

  • Chen JH. . 1980 J. Virol. 36: 162–170.

  • Chen RH, Fields S and Lipsick JS. . 1995 Oncogene 11: 1771–1779.

  • Chen RH and Lipsick JS. . 1993 Mol. Cell. Biol. 13: 4423–4431.

  • Clarke MF, Kukowska-Latallo JF, Westin E, Smith M and Prochownik EV. . 1988 Mol. Cell. Biol. 8: 884–892.

  • Dash AB, Orrico FC and Ness SA. . 1996 Genes. Dev. 10: 1858–1869.

  • DeGregori J, Kowalik T and Nevins JR. . 1995 Mol. Cell. Biol. 15: 4215–4224.

  • Dini PW, Eltman JT and Lipsick JS. . 1995 J. Virol. 69: 2515–2524.

  • Dini PW and Lipsick JS. . 1993 Mol. Cell. Biol. 13: 7334–7348.

  • Dubendorff JW, Whittaker LJ, Eltman JT and Lipsick JS. . 1992 Genes. Dev. 6: 2524–2535.

  • Duesberg PH, Bister K and Moscovici, C. . 1980 Proc. Natl. Acad. Sci. USA 77: 5120–5124.

  • Duprey SP and Boettiger D. . 1985 Proc. Natl. Acad. Sci. USA 82: 6937–6941.

  • Durban EM and Boettiger D. . 1981a Proceedings of the National Academy of Sciences USA 78: 3600–3604.

  • Durban EM and Boettiger D. . 1981b J. Virol. 37: 488–492.

  • Engelke U and Lipsick JS. . 1994 J. Virol. 68: 2752–2755.

  • Engelke U, Wang DM and Lipsick JS. . 1997 J. Virol. 71: 3760–3766.

  • Engelke U, Whittaker L and Lipsick JS. . 1995 Virology 208: 467–477.

  • Favier D and Gonda TJ. . 1994 Oncogene 9: 305–311.

  • Ferrao P, Macmillan EM, Ashman LK and Gonda TJ. . 1995 Oncogene 11: 1631–1638.

  • Frampton J, Ramqvist T and Graf T. . 1996 Genes. Dev. 10: 2720–2731.

  • Frykberg L, Metz T, Brady G, Introna M, Beug H, Vennstrom B and Graf T. . 1988 Oncogene Res. 3: 313–322.

  • Fu SL and Lipsick JS. . 1996 J. Virol. 70: 5600–5610.

  • Fu SL and Lipsick JS. . 1997 Cell Growth Differ. 8: 35–45.

  • Ganter B, Fu S and Lipsick JS. . 1998 EMBO J. 17: 255–268.

  • Ganter B and Lipsick JS. . 1997 Oncogene 15: 193–202.

  • Ganter B and Lipsick JS. . 1999 Advances in Cancer Research in press.

  • Garcia A, LaMontagne K, Reavis D, Stober-Grasser U and Lipsick JS. . 1991 Oncogene 6: 265–273.

  • Gazzolo L, Moscovici C and Moscovici MG. . 1979 Cell 16: 627–638.

  • Gazzolo L, Moscovici MG and Moscovici G. . 1975 Virology 67: 553–565.

  • Gerondakis S and Bishop JM. . 1986 Mol. Cell. Biol. 6: 3677–3684.

  • Golay J, Introna M and Graf T. . 1988 Cell 55: 1147–1158.

  • Gonda TJ, Buckmaster C and Ramsay RG. . 1989a EMBO J. 8: 1777–1783.

  • Gonda TJ, Ramsay RG and Johnson GR. . 1989b EMBO J. 8: 1767–1775.

  • Graf T, McNagny K, Brady G and Frampton J. . 1992 Cell 70: 201–213.

  • Graf T, Oker-Blom N, Todorov TG and Beug H. . 1979 Virology 99: 431–436.

  • Graf T, von Kirchbach A and Beug H. . 1981 Exp. Cell Res. 131: 331–343.

  • Grasser FA, Graf T and Lipsick JS. . 1991 Mol. Cell. Biol. 11: 3987–3996.

  • Grasser FA, LaMontagne K, Whittaker L, Stohr S and Lipsick JS. . 1992 Oncogene 7: 1005–1009.

  • Graves BJ and Petersen JM. . 1998 Adv. Cancer Res. 75: 1–55.

  • Hall WJ, Bean CW and Pollard M. . 1941 Am. J. Vet. Res. 2: 272–279.

  • Hateboer G, Gennissen A, Ramos YFM, Kerkhoven RM, Sonntag-Nuck V, Stunnenberg HG and Bernards R. . 1995 EMBO J. 14: 3159–3169.

  • Howe KM, Reakes CF and Watson RJ. . 1990 EMBO J. 9: 161–169.

  • Hu YL, Ramsay RG, Kanei-Ishii C, Ishii S and Gonda TJ. . 1991 Oncogene 6: 1549–1553.

  • Hurford Jr RK, Cobrinik D, Lee MH and Dyson N. . 1997 Genes Dev. 11: 1447–1463.

  • Ibanez CE, Garcia A, Stober-Grasser U and Lipsick JS. . 1988 J. Virol. 62: 4398–4402.

  • Ibanez CE and Lipsick JS. . 1988 J. Virol. 62: 1981–1988.

  • Ibanez CE and Lipsick JS. . 1990 Mol. Cell. Biol. 10: 2285–2293.

  • Introna M, Golay J, Frampton J, Nakano T, Ness SA and Graf T. . 1990 Cell 63: 1289–1297.

  • Ivanov X, Mladenov Z, Nedyalkov S and Todorov TG. . 1962 Bull. Inst. Path. Comp. Anim. Acad. Bulg. Sci. 9: 5–36.

  • Jiang W, Kanter MR, Dunkel I, Ramsay RG, Beemon KL and Hayward WS. . 1997 J. Virol. 71: 6526–6533.

  • Kalkbrenner F, Guehmann S and Moelling K. . 1990 Oncogene 5: 657–661.

  • Kanei-Ishii C, MacMillan EM, Nomura T, Sarai A, Ramsay RG, Aimoto S, Ishii S and Gonda TJ. . 1992 Proc. Natl. Acad. Sci. USA 89: 3088–3092.

  • Kanter MR, Smith RE and Hayward WS. . 1988 J. Virol. 62: 1423–1432.

  • Kiewitz A and Wolfes H. . 1997 FEBS Lett. 415: 258–262.

  • Klempnauer KH, Arnold H and Biedenkapp H. . 1989 Genes Dev. 3: 1582–1589.

  • Klempnauer KH and Bishop JM. . 1983 J. Virol. 48: 565–572.

  • Klempnauer KH, Gonda TJ and Bishop JM. . 1982 Cell 31: 453–463.

  • Klempnauer KH, Ramsay G, Bishop JM, Moscovici MG, Moscovici C, McGrath JP and Levinson AD. . 1983 Cell 33: 345–355.

  • Klempnauer KH and Sippell AE. . 1987 EMBO J. 6: 2719–2725.

  • Klempnauer KH, Symonds G, Evan GI and Bishop JM. . 1984 Cell 37: 537–547.

  • Kowenz-Leutz E, Herr P, Niss K and Leutz A. . 1997 Cell 91: 185–195.

  • Kulessa H, Frampton J and Graf T. . 1995 Genes. Dev. 9: 1250–1262.

  • Lane T, Ibanez C, Garcia A, Graf T and Lipsick J. . 1990 Mol. Cell. Biol. 10: 2591–2598.

  • Le Rouzic E and Perbal B. . 1996 J. Virol. 70: 7414–7423.

  • Leprince D, Gegonne A, Coll J, de Taisne C, Schneeberger A, Lagrou C and Stehelin D. . 1983 Nature 306: 395–397.

  • Leverson JD and Ness SA. . 1998 Mol. Cell. 1: 203–211.

  • Lipsick JS. . 1987 J. Virol. 61: 3284–3287.

  • Lipsick JS. . 1996 Oncogene 13: 223–235.

  • Lipsick JS and Ibanez CE. . 1987 J. Virol. 61: 933–936.

  • Lipsick JS, Ibanez CE and Baluda MA. . 1986 J. Virol. 59: 267–275.

  • Luscher B, Kuenzel EA, Krebs EG and Eisenman RN. . 1989 EMBO J. 8: 1111–1119.

  • McNagny KM and Graft T. . 1996 Curr. Top. Microbiol. Immunol. 212: 143–162.

  • Metz T and Graf T. . 1991a Cell 66: 95–105.

  • Metz T and Graf T. . 1991b Genes. Dev. 5: 369–380.

  • Metz T, Graf T and Leutz A. . 1991 EMBO J. 10: 837–844.

  • Mizuguchi G, Kanei-Ishii C, Takahashi T, Yasukawa T, Nagase T, Horikoshi M, Yamamoto T and Ishii S. . 1995 J. Biol. Chem. 270: 9384–9389.

  • Moscovici C. . 1985 In: Retroviruses and Human Pathology. Gallo RC, Stehelin D and Varnier OE (eds).. The Humana Press: Clifton pp177–191.

    Book  Google Scholar 

  • Moscovici C, Gazzolo L and Moscovici MG. . 1975 Virology 68: 173–181.

  • Moscovici C, Moscovici MG, Jiminez H, Lai MMC, Hayman MJ and Vogt PK. . 1977 Cell 11: 95–103.

  • Moscovici MG, Jurdic P, Samarut J, Gazzolo L, Mura CV and Moscovici C. . 1983a Virology 129: 65–78.

  • Moscovici MG and Moscovici C. . 1983 Proc. Natl. Acad. Sci. USA 80: 1421–1425.

  • Moscovici MG, Samarut J, Jurdic P, Gazzolo L and Moscovici C. . 1983b Virology 124: 185–187.

  • Mucenski ML, McLain K, Kier AB, Swerdlow SH, Schreiner CM, Miller TA, Pietryga DW, Scott Jr WJ and Potter SS. . 1991 Cell 65: 677–689.

  • Nakagoshi H, Nagase T, Ueno Y and Ishii S. . 1989 Nucleic Acids Res. 17: 7315–7324.

  • Ness SA. . 1996 Biochim. Biophys Acta 1288: F123–F139.

  • Ness SA, Marknell A and Graf T. . 1989 Cell 59: 1115–1125.

  • Nomura N, Takahashi M, Matsui M, Ishii S, Date T, Sasamoto S and Ishizaki R. . 1988 Nucleic Acids Res. 16: 11075–11089.

  • Nunn M, Weiher H, Bullock P and Duesberg P. . 1984 Virology 139: 330–339.

  • Ogata K, Hojo H, Aimoto S, Nakai T, Nakamura H, Sarai A, Ishii S and Nishimura Y. . 1992 Proc. Natl. Acad. Sci. USA 89: 6428–6432.

  • Ogata K, Morikawa S, Nakamura H, Sekikawa A, Inoue T, Kanai H, Sarai A, Ishii S and Nishimura Y. . 1994 Cell 79: 639–648.

  • Patel G, Kreider B, Rovera G and Reddy EP. . 1993 Mol. Cell. Biol. 13: 2269–2276.

  • Perbal B, Lipsick JS, Svoboda J, Silva RF and Baluda MA. . 1985 J. Virol. 56: 240–244.

  • Pessano S, Gazzolo L and Moscovici C. . 1979 Microbiologica 2: 379–392.

  • Press RD, Kim A, Ewert DL and Reddy EP. . 1992 J. Virol. 66: 5373–5383.

  • Press RD, Reddy EP and Ewert DL. . 1994 Mol. Cell. Biol. 14: 2278–2290.

  • Queva C, Ness SA, Grasser FA, Graf T, Vandenbunder B and Stehelin D. . 1992 Development 114: 125–133.

  • Radke K, Beug H, Kornfeld S and Graf T. . 1982 Cell 31: 643–653.

  • Ramsay RG, Ishii S and Gonda TJ. . 1991 Oncogene 6: 1875–1879.

  • Ramsay RG, Thompson MA, Hayman JA, Reid G, Gonda TJ and Whitehead RH. . 1992 Cell Growth Differ. 3: 723–730.

  • Ravel-Chapuis P, Leprince D, Pain B, Li R, Domenget C, Stehelin D, Samarut J and Jurdic P. . 1991 J. Virol. 65: 3928–3931.

  • Rossi F, McNagny M, Smith G, Frampton J and Graf T. . 1996 EMBO J. 15: 1894–1901.

  • Rosson D and Reddy EP. . 1986 Nature 319: 604–606.

  • Roussel M., Saule S, Lagrou C, Rommens C, Beug H, Graf T and Stehelin D. . 1979 Nature 281: 452–455.

  • Rushlow KE, Lautenberger JA, Reddy EP, Souza LM, Baluda MA, Chirikjian JG and Papas TS. . 1982 J. Virology 42: 840–846.

  • Sakura H, Kanei-Ishii C, Nagase T, Nakagoshi H, Gonda TJ and Ishii S. . 1989 Proc. Natl. Acad. Sci. USA 86: 5758–5762.

  • Saville MK and Watson RJ. . 1998 Adv. Cancer Res. 72: 109–140.

  • Schirm S, Moscovici G and Bishop JM. . 1990 J. Virol. 64: 767–773.

  • Selvakumaran M, Liebermann DA and Hoffman-Liebermann B. . 1992 Mol. Cell. Biol. 12: 2493–2500.

  • Seneca S, Punyammalee B, Sureau A, Perbal B, Dvorak M and Crabeel M. . 1993 Oncogene 8: 2335–2342.

  • Shen-Ong GL. . 1990 Biochim. Biophys. Acta 1032: 39–52.

  • Shen-Ong GL, Potter M, Mushinski JF, Lavu S and Reddy EP. . 1984 Science 226: 1077–1080.

  • Shen-Ong GL and Wolff L. . 1987 J. Virol. 61: 3721–3725.

  • Sitzmann J, Noben-Trauth K and Klempnauer KH. . 1995 Oncogene 11: 2273–2279.

  • Smarda J and Lipsick JS. . 1994 Oncogene 9: 237–245.

  • Smarda J, Sugarman J, Glass C and Lipsick J. . 1995 Mol. Cell. Biol. 15: 2474–2481.

  • Souza LM, Komaromy MC and Baluda MA. . 1980 Proceedings of the National Academy of Sciences USA 77: 3004–3008.

  • Stober-Grasser U and Lipsick JS. . 1988 J. Virol. 62: 1093–1096.

  • Symonds G, Klempnauer KH, Evan GI and Bishop JM. . 1984a Mol. Cell. Biol. 4: 2587–2593.

  • Symonds G, Stubblefield E, Guyaux M and Bishop JM. . 1984b Mol. Cell. Biol. 4: 1627–1630.

  • Tanaka Y, Nomura T and Ishii S. . 1997 Febs. Letters 413: 162–168.

  • Tavner FJ, Simpson R, Tashiro S, Favier D, Jenkins NA, Gilbert DJ, Copeland NG, Macmillan EM, Lutwyche J, Keough RA, Ishii S and Gonda TJ. . 1998 Mol. Cell. Biol. 18: 989–1002.

  • Todokoro K, Watson RJ, Higo H, Amanuma H, Kuramochi S, Yanagisawa H and Ikawa Y. . 1988 Proc. Natl. Acad. Sci. USA 85: 8900–8904.

  • Torelli G, Venturelli D, Colo A, Zanni C, Selleri L, Moretii L, Calabretta B and Torelli U. . 1987 Cancer Res. 47: 5266–5269.

  • Westin EH, Gallo RC, Arya SK, Eva A, Souza LM, Baluda MA, Aaronson SA and Wong-Staal F. . 1982 Proc. Natl. Acad. Sci. USA 79: 2194–2198.

  • Weston K. . 1992 Nucleic Acids Res. 20: 3043–3049.

  • Weston K and Bishop JM. . 1989 Cell 58: 85–93.

  • Worpenberg S, Burk O and Klempnauer KH. . 1997 Oncogene 15: 213–221.

  • Zemanov K and Smarda J. . 1998 Blood Cells Mol. Dis. 24: 239–250.

Download references

Acknowledgements

We thank the members of our laboratory past and present for helpful discussions and the National Cancer Institute of the USPHS for research grant support. DM Wang was supported by USPHS grant T32 CA09151.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lipsick, J., Wang, DM. Transformation by v-Myb. Oncogene 18, 3047–3055 (1999). https://doi.org/10.1038/sj.onc.1202745

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202745

Keywords

This article is cited by

Search

Quick links